159 related articles for article (PubMed ID: 30624802)
1. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
[TBL] [Abstract][Full Text] [Related]
2. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
[TBL] [Abstract][Full Text] [Related]
3. The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts.
Lopert P; Abdelrahman S; Graybill CA; Rhodes J; Sørensen B; Li M; Hu Y; Wu D; Liu L; He P; Zhang X; Huang F; Hu J; Bill J
J Clin Apher; 2022 Dec; 37(6):544-552. PubMed ID: 36102144
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of therapeutic platelet depletion with Spectra Optia in a pregnant woman.
Małachowski R; Grzybowska-Izydorczyk O; Besson N; Szmigielska-Kapłon A; Nowicki M; Wierzbowska A
Transfus Apher Sci; 2017 Aug; 56(4):563-565. PubMed ID: 28803005
[TBL] [Abstract][Full Text] [Related]
5. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
Das SS; Bhattacharya S; Sen S
Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
[TBL] [Abstract][Full Text] [Related]
6. The effect of thrombocytapheresis on hemogram and biochemistry parameters in patients with essential thrombocytemia.
Kaya A; Kuku İ; Erkurt MA; Kaya E; Berber İ; Biçim S; Hidayet E; Cırık S; Arslan S; Yagin FH; Sarıcı A
Transfus Clin Biol; 2023 Nov; 30(4):421-425. PubMed ID: 37558046
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single-institution experience.
Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; Wheeler J
J Clin Apher; 2021 Feb; 36(1):101-108. PubMed ID: 33037852
[TBL] [Abstract][Full Text] [Related]
9. The role of thrombocytapheresis in the management of extreme thrombocytosis: a 6 years' experience from a tertiary care center.
Chenna D; Polavarapu I; Kandasamy D; Mohan G; Shastry S
Med Pharm Rep; 2021 Oct; 94(4):434-439. PubMed ID: 36105497
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic thrombocytapheresis: a review of 132 patients.
Adami R
Int J Artif Organs; 1993 Dec; 16 Suppl 5():183-4. PubMed ID: 8013984
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
12. [Essential thrombocythemia as a cause of headache in young woman].
Bieniaszewska M; Balon J; Hellmann A
Pol Merkur Lekarski; 2000 Jul; 8(49):479-80. PubMed ID: 11070720
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
[No Abstract] [Full Text] [Related]
14. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
Baron BW; Mick R; Baron JM
Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
[TBL] [Abstract][Full Text] [Related]
15. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
McCarthy LJ; Graves VL; Eigen H; McGuire WA
Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report.
Elhassan AM; Alsaud A; Yassin MA; Aldapt M; Riaz L; Ghori F; Bin Ahmad A; Abdulla M
Case Rep Oncol; 2020; 13(2):675-679. PubMed ID: 32774255
[TBL] [Abstract][Full Text] [Related]
18. Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis.
Au WY; Liu CL; Lo CM; Fan ST; Ma SK
J Clin Apher; 2004; 19(4):192-6. PubMed ID: 15597348
[TBL] [Abstract][Full Text] [Related]
19. Plateletpheresis: Nonoperative Management of Symptomatic Carotid Thrombosis in a Patient with Reactive Thrombocytosis.
Martínez RC; Quaynor S; Alkhalifah M; Goldenberg FD
World Neurosurg; 2018 Jun; 114():126-129. PubMed ID: 29555611
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Thrombocytapheresis for Symptomatic Thrombocytosis in Hemato-Oncology Patients.
Prakash S; Hans R; Sharma RR; Malhotra P; Marwaha N
Ther Apher Dial; 2018 Feb; 22(1):93-95. PubMed ID: 29205870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
